(FY)Dec 30, 2021 | (FY)Dec 30, 2020 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | -46.60%-14.48M | -9.88M |
Other cash income from operating activities | -46.60%-14.48M | ---9.88M |
Cash paid | ||
Operating cash flow | -46.60%-14.48M | ---9.88M |
Investing cash flow | ||
Cash flow from continuing investing activities | -143.57%-682K | -280K |
Net PPE purchase and sale | -346.15%-58K | ---13K |
Net intangibles purchas and sale | -133.71%-624K | ---267K |
Cash from discontinued investing activities | ||
Investing cash flow | -143.57%-682K | ---280K |
Financing cash flow | ||
Cash flow from continuing financing activities | -98.26%449K | 25.84M |
Net issuance payments of debt | -92.55%361K | --4.85M |
Net common stock issuance | -99.58%88K | --20.99M |
Cash from discontinued financing activities | ||
Financing cash flow | -98.26%449K | --25.84M |
Net cash flow | ||
Beginning cash position | 227.11%22.59M | --6.91M |
Current changes in cash | -193.85%-14.72M | --15.68M |
End cash Position | -65.16%7.87M | --22.59M |
Free cash from | -49.27%-15.17M | ---10.16M |
Accounting Standards | US-GAAP | US-GAAP |
No Data
No Data